Kenanga Research places ‘outperform’ rating on Kotra

KUALA LUMPUR: The bright outlook for Malaysia’s over-the-counter (OTC) industry is expected to augur well for Kotra Industries Bhd as the segment makes up 53 per cent of its financial year 2022 revenue. 

Author(s): -
Copyright: NSTP
Published on: 9 December 2022
Publication: New Straits Times
Items linked to this story
NST - Fri, 12 2022 CM 015 a
KOTRA PHARMA / TAMAN TEKNOLOGI CHENG
25097439
Contact us for more information on License Usage.
Additional fees
Historical Fee
RM37.00
(Includes 8% SST) RM112.60